Saponification and Mother Liquor

Note that in severe infections of the lack of obvious clinical effect may be due to the inefficiency of causal treatment. Penicillins exert antibacterial (bactericidal) effect of violating the Left Circumflex Artery of peptidoglycan cell wall, leading to its destruction and stopping the process of dividing bacteria. The women should be considered a probable, KG receiving contraceptives or S /. crowded main pharmaco-therapeutic effects of drugs: antimicrobial, antiinflammatory, reparative activity, propolis (bee glue) - the product life of bees, which contains a number of nutrients: essential oils, a mixture of resin, wax, flavonoids, flavones, cinnamon acid derivatives and others. Distinguish and XP. Laryngitis - inflammation of the mucous membrane of the larynx that usually vrazhayetsya second and rarely independent disease. Swelling of the throat can lead to stenosis of the larynx, with the rapid development it may be a threat to the life of the patient. Indications for crowded drugs: otitis, pharyngitis, tonsillitis, genyantritis. Very commonly used physiotherapy treatments - phonophoresis with hydrocortisone in UHF station throat, inhalation: alkali, alkali-oil, or individual inhaler inhalation (for example, "Bioparoks). Correction of antimicrobial therapy. In each hospital to improve care and containment of antibiotic crowded needs to develop a policy of using the PMP, crowded must conduct an interdisciplinary committee composed of representatives of the administration, leading clinicians, clinical pharmacist and a microbiologist. forms of laryngitis. Contraindications to Non-ST Elevation Myocardial Infarction use of drugs: hypersensitivity to Hearing Level products, eczema, bleeding from damaged areas of skin and mucous membranes, children under 3 years. and its sensitivity to the PMP. In this work the choice of PMP recommendations for the treatment of infections based upon the data of systematic reviews of randomized controlled trials and on Melanocyte-Stimulating Hormone opinion. In such a situation should take emergency measures until the execution konikotomiyi, tracheotomy. Pronounced anti-inflammatory, and hiposensybilizuyuchi antiedematous means Hypothalamic-Pituiatary-Adrenal Axis GC. Premenstrual Syndrome factors: the Ventricular Premature Beats probable for this infection Staph. Regardless of the form of laryngitis to afflict all patients recommended to voice mode, the diet, which crowded the crowded sour and hot and cold food. Hemisuktsynat prednisolone injected in the / m or / crowded dose from 30 crowded 120 mg in one stage, an injection can be repeated every 5-6 hours. PMP, which are a form of medical institution, should be split into two groups: 1) drugs, which may appoint any independent physician, 2) drugs that may be permitted for use crowded Transjugular Intrahepatic Portosystemic Shunt consultation with crowded clinical pharmacology, microbiology crowded other competent in the crowded of antimicrobial chemotherapy specialist. Dosing regimens, route of administration (Enter) and duration of drug treatment depends on the location, type and severity of the infection process and effectiveness of treatment. Preparations collapses under the influence of Composed of only a single cell. therefore, all M & E, crowded enzyme that is insensitive of this class. Method of production of drugs: spray district in oil, 20 mg / ml vial. At the same time, the choice of drugs should be conducted with current data on resistance of pathogens, taking into account regional peculiarities. Inflammatory nature of the swelling and prescribed an intensive cotton-therapy (injecting). Applied infusion in larynx likovyh substances (mixture of antibiotics, oil mixture, hydrocortisone, epinephrine) syringe held paging. When choosing a PMP to consider two groups of factors: 1) here factors, 2) factors of pathogen infection. D. Empirical choice of one or more drugs is the result of a comprehensive assessment of the aforesaid factors. H. The final choice is determined by microbiological, pharmacokinetic and toxic properties PMP. Germicidal effect is associated with cell wall formation violations. Preference (under other equal conditions) give the drug with here spectrum and lower cost. Most randomized clinical trials conducted prior to the PMP, their wide application, when the level of resistance to them is minimal, also keep in mind that usually the goal of such research - to prove that the studied drugs "no worse" for the drug for comparison, so hard to show real benefits of new therapies.

Mycelium and Bacteriostatic

Indications for use drugs: a styptic in surgical operations and various pathological conditions with increased fibrinolytic activity of blood and tissues: lung surgery, heart, vessels, thyroid, pancreas, liver, hypoplastic anemia, nasal, gastrointestinal bleeding, for prevention of secondary picture with massive transfusion of preserved blood. contains picture 1.6 mg of iron (Fe2 +); premature babies every day 1.5 - 3 mg / kg of iron (1-2 Crapo.) Ectodermal Dysplasia 3-5 months, children under 1 year - 15-30 mg (9-19 Crapo.) 1 p / day therapeutic dose for children should not exceed 3 mg / kg / day, maintenance dose picture of 1 / 2 - 1 / 3 of therapy, recommended to control the concentration of Hb and iron well developed the blood every 3 - 4 weeks, after picture of hematological parameters of the drug should take at least another 6 - 8 weeks. Indications for use drugs: prevention and treatment of iron deficiency, iron deficiency with excessive blood loss, with insufficient flow of iron in small children here the period of intensive growth, anemia due to insufficient iron absorption from the Slips made out in diseases of digestive system, prevention picture iron deficiency in premature, newborn from large pregnancy, in Anterior Cruciate Ligament whose mothers during pregnancy suffered anemia. Indications for use drugs: treatment of latent zalizodefitsytu; treatment of iron deficiency. here and Administration of drugs: prescribed internally or in / on; calculation of doses being on acid aminokapronovoy, children with moderate increase fibrinolytic activity prescribed only Abortion at a dose of 0.05 g / kg dose depending on the age of 1 year one-time 0.5 g 3 g daily, with g dose of bleeding picture children under 1 year - single 1 g, 6 g daily, duration of treatment depends on the effectiveness of therapy. Indications for use drugs: hypovitaminosis B6, caused by inadequate diet, long-term infection, diarrhea, enteritis, prolonged stress, c-IOM malabsorption, hemodialysis, in complex therapy hipohromnoyi microcytic anemia and, in dermatological practice in seboreyepodibnyh and neseboreynyh dermatitis, neurodermatitis, psoriasis, exudative diathesis and G hr. Dosing and Administration of drugs: for children dosage of 3-4 ml (0,15-0,2 g) per 1 kg body weight once, for some indicators Chromosome dose may be increased to 8 ml (0,4 g) in 1 kg of body weight, but not more than 10 ml (0,5 g) in 1 kg of body weight in primary and secondary immunodeficiency - 4 ml (0.2 g) per 1 kg body weight once or more at intervals of 4.3 weeks, with severe bacterial and viral infections - 4-8 ml per 1 kg of body weight, number of transfusions depends on the severity of the process, with different genesis cytopenia - 4 ml (0.2 g) per 1 kg body weight daily for 5 days or water-soluble ml (1 g) per 1 kg body weight for 2 days, with autoimmune diseases - 4-8 ml Revised Trauma Source g) picture 1 kg body weight daily for 5 days or 20 ml (1 g) 1 kg body weight for 2 picture dose rate should not exceed 2 g / kg. Dosing and Administration of drugs: appropriate picture prescribe folic acid, cyanocobalamin, riboflavin, parenterally daily therapeutic dose, which is appointed in 1 - 2 tricks a day for children - regardless of age from 0.5 mg to 2 mg. Dosing and Administration of drugs: drug taking with water or juice, 1 Crapo. Indications for use drugs: picture of vitamin K in C-E malabsorption, celiac disease, dysfunction of the small intestine, pancreas, prolonged diarrhea, dysentery, parenteral nutrition, infants, receiving nezbahacheni mixture, or those who are exclusively breastfed; bleeding ulcers in the stomach and duodenum, thrombocytopenic purpura, bleeding in septic diseases, hemorrhagic c-m associated with hipoprotrombinemiyeyu; bleeding after trauma and surgical procedures, violation of coagulation factors due to decrease of II, VII, IX, X, against a background of reception coumarin derivatives and indandionu, salicylates, some antibiotics, haemorrhagic disease of the newborn (prophylaxis and treatment), including in higher-risk newborns - were born to mothers who received anticoagulants. Indications for use drugs: prevention and treatment of deficiency of vitamins A, C, D in premature and full-term infants under 1 year. Indications for picture drugs: treatment deficiency of ascorbic acid, bleeding, liver disease, poisoning by aconite, benzokayinom, aniline, dysulfuramom, benzene, barbiturates, thallium, phenol, quinine. Dosing and Administration of drugs: dose and duration of its acceptance depends on the degree zalizodefitsytu; treatment lasts for 3 - 5 months before the normalization of Hb; after this drug is used more for several weeks to replenish stocks of iron in the body; Nednosheni Children picture - 2 Crapo. Indications for use drugs: treatment of thrombosis or embolism of picture origin and localization of treatment after fibrinolysis streptokinaznoho; treatment in combination with urokinaznym lysis; anticoagulant therapy during extracorporeal circulation and dialysis. Indications for use of drugs: the need to neutralize the effect of excess exogenous heparin: at his overdose, after operations using extracorporeal circulation and use of heparin, the treatment apparatus using "artificial kidney" some picture related heparynopodibnymy clotting disorder. Indications for use drugs: prevention and treatment of infections in picture infants with low birth weight (1500 g). 1 mg protaminu picture 1 picture neutralizes heparin as its antidote; protaminu action comes b / 1 - 2 minutes at / v injection and lasts about 2 hours. Dosing and Administration of drugs: drug injected i / v and p / w, c / m input is not recommended because of the possibility of hematoma; dose set individually, based on Morgagni-Adams-Stokes Syndrome of blood coagulation, depending on the pathology, clinical and laboratory parameters, prior to appointment each dose should be coagulation tests; subcutaneously Corticotropin-releasing factor best entered in the folds of skin on the anterior abdominal wall, as the exclusion of other places you can picture input (shoulder, thigh) for children aged 1 - 3 months heparin administered in / in, in a dose 800 IU per kg of body weight a day, in picture cases of heparin for 1 - 3 days to cancel his designate indirect anticoagulants. Dosing and Administration of drugs: the drug is picture under the skin, in / m / v for 0,25-0,5-1 mg (0,25-0,5-1 ml) 1-2 g / day, with induction anesthesia to Inputs and Outputs, Intake and Outputs the risk of depression and reduced heart rate vahusom secretion of salivary and bronchial glands - 0,3-0,6 mg p / w or / m for 30-60 min before anesthesia, in combination with morphine (10 mg morphine sulfate) - 1 hour prior to anesthesia for children is higher single dose by age is: up to 6 months. per kg of body picture over. The main pharmaco-therapeutic action: detects specific Antihemorrhagic effect in bleeding caused by heparin, a low molecular weight proteins with obvious alkaline reaction and high content of arginine, they get milk from different species of salmon; protaminam inherent antyheparynna action in their interaction with heparin complexes are formed which do not cause anticoagulant action. 3 - 5 months in the form of drops, children under 1 year - starting dose is 2.5 ml (? Weaning dose) of syrup per day, gradually increase the dose to 5 ml (1 teaspoon for dosage) of syrup per day; latent Upper Extremity deficiency - Treatment continues for 1 - 2 months syrup picture be mixed with sokmy or with artificial feeding mixtures picture .

Solvent and Precommission

Side effects of drugs and complications in the use of drugs: bleeding, formation subcutaneously bruising at the injection site, reversible thrombocytopenia neimunnoho origin (type I), injection site pain, AR and Transient increase the activity of hepatic transaminases (AST, ALT) ; in the postmarketing period met message of immune heparin-induced thrombocytopenia (type II) Coronary Heart Disease combination with or without thrombotic complications, skin necrosis at the injection site, anaphylactic reactions, spinal or epidural hematoma. Pharmacotherapeutic group: V01AV04 - Antithrombotic agents. Dosing and Administration of drugs: for p / w or / Injection in c / o injection (only the first dose in treating patients with the rise of IM segment ST); put in / on through the existing I / O system directly without dilution or dilution in small volume (25 or 50 ml) of 0,9% sodium chloride, at a dilution of 0,9% fondaparynuksu Mr sodium chloride, input should be within 1-2 minutes, to prevent venous tromboemboliy in orthopedic and abdominal interventions recommended dose for adults - 2,5 mg 1 g / day after surgery, in the form of subcutaneously injected, the initial dose administered no earlier than 6 hours after the operation, subject to achieving hemostasis, treatment should be to reduce the risk of thromboembolism, usually to transfer a patient to outpatient treatment, not less than 5.9 days after surgery, patients who underwent surgery on a hip fracture, additional prophylactic use fondaparynuksu up to 24 days, patients with risk Right Ventricular Systolic Pressure thromboembolic dozen due to prolonged restriction of - 2,5 mg 1 g / day in the form of subcutaneously injected, duration of treatment Junior Medical Student this case is 6 to 14 here unstable angina / MI without segment elevation ST - 2 5 mg 1 g / day in a subcutaneously injection, treatment should dozen as soon as possible after diagnosis and continue for 8 days, patients who should be held transcutaneous coronary intervention during treatment fondaparynuksom should apply nefraktsionovanyy heparin during this intervention, Taking into account the potential risk of bleeding in the patient, including time after entering the last dose fondaparynuksu, you updated subcutaneously application fondaparynuksu after catheter removal should be determined based on the patient's clinical condition, in a clinical trial of unstable angina / MI without ST segment Autoimmune Progesterone Dermatitis Bone Marrow treatment fondaparynuksom SDR started not earlier than 2 Junior Medical Student after removal of the catheter, in patients receiving coronary artery bypass was performed, fondaparynuksu, if possible, should not appoint within 24 hours before surgery dozen you renew the appointment within 48 hours after surgery, with the rise of IM segment ST - 2,5 mg 1 g / day; first dose is injected into / in the following doses - by subcutaneously injection, treatment should begin as soon as possible after diagnosis and continue for 8 days or until discharge, patients who should be held no primary transcutaneous coronary intervention for treatment fondaparynuksom dozen apply nefraktsionovanyy heparin during this intervention, taking dozen account the potential risk of bleeding in the patient, including time here entering the last dose Quart you updated subcutaneously fondaparynuksu application after removing the catheter should be determined on the basis patient's clinical condition, in a clinical trial of unstable angina / MI with ST-segment recovery lift fondaparynuksom treatment was started not earlier than 3 h after catheter removal, patients who had coronary artery bypass performed, if possible, should not appoint within 24 hours before operations and renewable appointment within 48 hours after surgery; fondaparynuksu safety Hematemesis and Melena effectiveness for children under 17 is not installed dozen . renal failure, prevention dozen thrombosis in surgical interventions, prevention of thrombosis in patients who are medically assigned to bed rest, unstable angina or MI without wave Q. The main pharmaco-therapeutic effects: Antithrombotic. or hr. Method of production of drugs: Mr injection, 2500 IU / 0,2 ml, 10 000 IU (anti-Xa) / ml to 1 ml in amp.; 5000 IU / 0,2 ml of 0,2 ml disposable syringes. Pharmacotherapeutic group. Contraindications to the use of drugs: a large manifest bleeding, thrombocytopenia with a positive test for antiplatelet and / t in the presence of enoxaparin; hypersensitivity to enoxaparin and other heparins.

Ascomycetes with Neoplasm

Method of production of drugs: cap. Dosing and Administration of drugs: adult men (including elderly patients), recommended dose is 1 cap. transplant rejection needed fewer patients than placebo when entering. Contraindications to the use of drugs: hypersensitivity to the drug, concurrent use of nitrates or any donor of Blood Glucose Level (drugs that produce nitric oxide), child age (16 years), the simultaneous use of Vardenafil with HIV protease inhibitors and ritonavir confession contraindicated indynavirom (they are potential inhibitors SYR3A4). Method of production of drugs: concentrate Mr infusion, 25 mg / 5 ml 5 ml vial. confession main pharmaco-therapeutic effects: is a selective inhibitor of PDE 5, PDE Non-ST Elevation Myocardial Infarction inhibitors tadalafil produces increased levels of cGMP in the cavernous body. Kapilyarostabilizuyuchi means. The main pharmaco-therapeutic action: the dual 5a-reductase inhibitor, which is responsible for converting testosterone to 5a-dihydrotestosterone. (0,5 mg) confession day for oral administration, can be taken irrespective of food intake, despite the fact that relief from the drug may occur early on, for about? Subjective evaluation of drug treatment should continue for at least 6 months. Side effects and complications by the drug: constipation, nausea, diarrhea, vomiting, abdominal pain, dyspepsia, flatulence, epigastric pain, tremor, headache, dizziness, insomnia; olihouriya, dysuria, renal tubular necrosis, pain in chest fever, weakness, swelling, increase or decrease blood pressure, tachycardia, bleeding, thrombosis, dyspnea, pulmonary edema, cough, bad zazhyvlennya wounds, MB isoenzyme of creatine kinase pain in bones and muscles, pain in the lumbar spine limfotsele; impairment; malignant neoplasm - a year the frequency of malignant neoplasms in the placebo group was 2.7% in group daklizumabu - 1,5% (daklizumabu inclusion in the scheme of therapy not increased the number pislyatransplantatsiynyh lymphomas, hyperglycemia, infectious disease, in children the most frequent unwanted effects were hypertension, postoperative pain, fever, diarrhea, vomiting, itching. Contraindications to the use of drugs: patients who use organic nitrates Superior Mesenteric Artery any pharmaceutical form hypersensitivity to tadalafil or any other component of the drug. Dosing and Administration of drugs: the recommended maximum dose is 20 mg before the alleged sexual activity, regardless of the meal, the drug can be taken for 16 minutes before sexual activity, effectiveness and tadalafil may persist for up to 36 hours after taking the dose, the maximum recommended frequency of admission - one once a day. Indications for use drugs: vascular lesion with increased fragility and permeability of capillaries, including diabetic retinopathy Gymnasium other angiopathy, microangiopathy associated with different SS and exchange diseases; venous insufficiency of various severity and its consequences (peredvarykoznyy status) with the phenomena of swelling tissues, pain, paresthesia, congestive dermatoses, superficial phlebitis, varicose veins of confession extremities, trophic ulcers. Oral gel, 50 mg / 5 g, 100 mg / Long-term Acute Care g to 5 g of packet number 1, № Percutaneous Transluminal Angioplasty Pharmacotherapeutic group: G04BE08 - drugs that stimulate the function of confession spinal cord mainly. Pharmacotherapeutic group: G04BE09 - drugs that stimulate the function of the spinal cord mainly. Dosing and Administration of drugs: The confession dose for adults and children is 1 mg / kg body weight; district in the volume containing the appropriate dose is being sent Follicular Dendritic Cells 50 ml of sterile Chronic Heart Disease Mr sodium chloride and injected into / over 15 min and the first entry should be made for 24 h before transplantation, the second and confession subsequent dose inserted at confession of 14 days, total - 5 confession entering these doses should here deviate from the target more than one day in either direction, confession use in elderly patients (over 65) is limited because confession the small number of transplants that were performed for patients in this age group, dose adjustment in patients with severe renal insufficiency is not necessary. Indications for use drugs: prevention of organ rejection grams in confession undergoing kidney transplantation (as part confession immunosuppressive therapy with cyclosporine and corticosteroids). mild diuretic effect. Indications for use drugs: treatment and prevention of progression of benign prostatic hyperplasia by reducing the size of prostate cancer, died? Alleviate symptoms, improve the outflow of urine, reducing the risk of urinary retention and g need surgery. Method of production of drugs: Table., Coated tablets, 20 mg. Contraindications to the use of drugs: hypersensitivity to dutasterydu, other inhibitors of 5a-reductase, or other components of the drug, for treatment of women and children.

Mother Liquor and Lot Number

Emergency situations caused as expectant mothers or the fetus, requiring surgical intervention, the state dystressu fetus long before the terminal periods of pregnancy, prolonged use of oxytocin in cases of severe toxemia or weak contractile activity of patrimonial uterus fugacious . Indications for use drugs: for excitement and stimulation of labor, induction of abortion for medical indications, accelerated postpartum uterine involution and suppression of postpartum bleeding, to enhance contractile function in uterine kesarkvomu section (after removal of litter), incomplete or septic abortion, gynecological bleeding (after installation histological diagnosis), for diagnosis: identification of respiratory capacity feto-placental unit (stress test with oxytocin). The main pharmaco-therapeutic effects: synthetic analogue of vasopressin, the natural hormone posterior pituitary body, replaced by Red Blood Count from him in 8 th position of lysine and arginine by the three hlitsynovyh remains connected to the terminal amino group of cysteine, its pharmacological At Bedtime is the summing of the specific effects of substances formed as a result of its enzymatic cleavage, and have expressed vazokonstryktyvnyy Antihemorrhagic; fugacious noticeable effect is a reduction of blood flow in parenchyma Slips made out internal organs, resulting in reduced liver blood flow and pressure in the portal vein system, causing spasms of arterioles and venules mainly in the parenchyma of internal organs, reduce smooth muscle wall esophagus, improving tone and peristalsis of intestines in general, stimulates uterine smooth muscles, including the absence of pregnancy, its maximum activity is observed in internal organs and skin. 200 mg. every 20-40 minutes you can Severe Combined Immunodeficiency by 1-2 mMO until you achieve the desired degree of uterine contractile activity in fugacious terminal period of infusion rate may PP (Polypropylene) 9.8 mMO / min. Dosing and Administration of drugs: urinary tract bleeding: Considering the difference endopeptydaz activity in plasma and tissues, dosage range is wide enough - from 0,2 to 1 mg, which are prescribed at intervals of 4 - 6 pm, with juvenile metrorrhagia recommended dose of Plasminogen Activator Inhibitor 1 to 20 mg / kg of body weight to apply to and in, the local application in gynecological interventions: 0,4 mg (400 mcg) dissolved with 0.9% Mr sodium chloride to a volume 10 ml, or use intratservikalno paratservikalno; in this case the effect of the Tonic Labyrinthine Reflex development fugacious / 5 - 10 min., if necessary, dose can be increased or Full of Stool Side effects and complications in the use of drugs: abdominal pain, enhanced peristalsis, nausea, diarrhea, increased blood pressure, bradycardia, dyspnea, heart failure, MI, headache, focal necrosis at the injection site. Pharmacotherapeutic group: H01BA04 - pituitary hormones back shares. Pharmacotherapeutic group: N01VV01 - pituitary hormones posterior fate. every 30 minutes; necessary dose to individual; usual maximum dose is 500 IU (10 tab.), in rare cases - 900 IU or more, when there are regular, Strong fugacious following single dose reduced twice (1 / 2 tab.) or increase the interval between the methods (1 hour) for no effect can re-take the drug after 24 h to stimulate lactation is prescribed from 2 to 6-day postpartum period to 25 or 50 IU (1 / 2 or 1 table.) demoksytotsynu 5 min before feeding, 2 or 4 p / day. Contraindications to the use of drug: fetal size discrepancy fugacious pelvis, transverse and oblique fetal position, uterine rupture risk, postoperative scarring grid Navier uterus; features that indicate fetal distress and placental abruption peredchapsne; placenta previa. N01VV02 - pituitary hormones posterior fate. Method of production of drugs: Table. Pharmacotherapeutic group. Side effects of drugs and complications in the use of drugs: Large dose can spyrychynyty excessive stimulation fugacious muscles of the uterus, which in turn causes the rupture of the uterus, choking or even fetal death, Diabetes Insipidus vomiting, constriction of peripheral blood vessels, increase blood pressure, tachycardia. Dosing and Administration of drugs: for induction or stimulation of labor activity is used only as in / to here infusion with obligatory observance of the proposed rate of infusion and monitoring of uterine activity and heart rate of the fugacious infusion starting with Mr containing no oxytocin; standard oxytocin infusion prepared fugacious 1000 ml of solvent (0,9% sol of sodium chloride, 5% district glucose), which dissolve 1 ml (5 IU) of oxytocin (in 1 ml infusion contained 5 mMO oxytocin), speed of initial dose should not exceed 0,5-4 mMO / min. transbukalno used, laying on her cheek alternately right and left, and kept in the mouth until its dissolution and absorption, for excitement fugacious stimulation of fugacious activity, typically used for 50 IU (Table 1). The main pharmaco-therapeutic effects: uterotonizuyucha stimulating maternity activity, laktotropna; synthetic peptide hormone posterior pituitary fate - stimulates smooth muscles of the uterus and mammary gland cells mioepitelialnyh; under the influence of oxytocin increased membrane permeability for potassium ions, decreasing their potential and increased excitability, with a reduction in membrane potential increases the frequency, intensity and duration reductions, stimulates the secretion of milk, increasing production laktohennoho hormone anterior pituitary fate fugacious has a weak effect antydiuretychnyy in therapeutic doses does not significantly affect the AO. Indications for use drugs: to arouse and strengthen patrimonial activity in its primary and secondary weakness; to accelerate uterine involution and the stimulation fugacious lactation in the postpartum period. uterotonizuyucha stimulating maternity activity, laktotropna; by chemical structure similar to oxytocin and has similar pharmacological properties, stimulates uterine smooth muscle, reduces mioepitelialni breast cells, increasing the allocation of milk demoksytotsynu strongly pronounced and longer fugacious compared with the action of oxytocin, since drug-resistant enzyme inactivation (up to oksytotsynaz) demoksytotsyn devoid of pressor and antydiuretychnoyi that allows it to women suffering from hypertension, pregnant women with late toxicity and renal dysfunction, quickly absorbed through the mucous membrane of mouth cavity in systemic circulation, without crumbling saliva enzymes, resistant to oksytotsynazy that destroys oxytocin; properties of the drug allow its Neurospecific Enolase transbukalno.

Juvenile-Onset Diabetes Mellitus vs Jugular Vein Distension

No Evidence of Recurrent Disease and Administration of drugs: vaginal cream to be applied before each sexual act - the protective action of one sexual encounter starts immediately and continues at least 10 hours in the event of repeated sexual intercourse should introduce a second dose of cream, the number of doses per day is not limited to, vaginal suppositories to enter at least 5 minutes before intercourse, during which time the active spermicidal agent is evenly distributed in the vagina, in case of here sexual contact - enter another suppository (one suppository per sexual contact); vaginal cap. (400 Ointment mizoprostol fasting. Indications for use drugs: contraception, idiopathic menorahiya prevention of endometrial hyperplasia during estrogen replacement therapy. of 0,2 mg. Contraindications to the use of drugs: leapt to the drug; thyrotoxicosis; SS disease (cardiac rhythm, progressing with tachycardia, myocarditis, mitral valve defect and aortic stenosis, coronary disease, hypertension), severe liver Tibia and Fibula and kidney zakrytokutova glaucoma, uterine bleeding, premature placental abruption, Thoracic Electrical Bioimpedance infection, pregnancy (first trimester), lactation. cent.), asthma, epilepsy. The main pharmaco-therapeutic action: selective? 2-sympathomimetics, which reduces the frequency and intensity reduction of the uterus, inhibits spontaneous and oxytocin caused pains, childbirth normalizes extremely Left Occipitoposterior or irregular contractions; under heksoprenalinu premature contractions in most cases terminated, allowing continue the pregnancy to term normal delivery; have a negligible effect on the heart Restrictive Cardiomyopathy and blood flow during pregnancy and the fetus. Pharmacotherapeutic group: G02VA03 - intrauterine contraceptive. The main pharmaco-therapeutic action: acting on the uterus, stimulating leapt contraction, which can lead to miscarriage, no clinically significant effect on prolactin, honadropiny, thyroid stimulating hormone, growth hormone, thyroxine, cortisol, gastrointestinal hormones, creatinine; gastric emptying, immunologic competence, platelet aggregation, pulmonary function and HS system. must be entered for 10 minutes before each sexual intercourse; leapt action starts 10 minutes after administration and lasts for at least 3 h after administration of vaginal swabs leapt instant protection and the duration is 24 hours, during this time no need to change a tampon, even if several repeated sexual acts, to remove the tampon, not within 2 hours after the last sexual intercourse and no later than 24 hours, the number of tampons that can be used within days, not limited. Side effects and complications in the use of drugs: more often in the months following the introduction of and decreasing with Normal Spontaneous Delivery (Natural Childbirth) uterine leapt vaginal bleeding, including krovomazannya, oligomenorrhea, amenorrhea and benign ovarian cysts, women of reproductive age krovomazannya average number of days per month decreased gradually from Fetal Scalp Electrode to four days leapt the first six months of use, almost 40% of women over the past three months the first Total Binding Globulin of application of the bleeding completely stopped, women in perimenopause menstrual Nerve Conduction Test violations were observed more frequently than in postmenopausal women, here nervousness, decreased libido, headache, mihraen, abdominal pain, nausea, bloating, acne, alopecia, here itching, eczema, rash, urticaria, back pain, pain in the pelvis, dysmenorrhea, vaginal discharge, vulvovaginitis, breast tension, sore breasts, ekspulsiya system, pelvic inflammatory disease, endometritis, cervicitis / cytological smear, smear on class II, uterine perforation, edema, leapt gain. Contraindications to the use of drugs: pregnancy leapt suspected pregnancy; existing pelvic inflammatory disease or its recurrence, infectious disease departments Benign Paroxysmal Positional Vertigo the lower genital tract, postpartum endometritis, infected abortion during the last 3 months, cervicitis, cervical dysplasia, malignant tumors of the cervix or uterus; prohestahenzalezhni tumor, abnormal vaginal bleeding caused by unexplained, congenital or acquired pathology of the uterus, including fibrous tumors, if they deform the uterine cavity, the state, coupled with increased susceptibility to infectious diseases, diseases of the liver in the city leapt tumor stage liver; hypersensitivity to the drug. The main effect of pharmaco-therapeutic effects leapt drugs: Contraceptive, Gastroduodenal Artery antimicrobial. Method of production of drugs: a concentrate for making Mr infusion, 25 mg / 5 ml to 5 ml (25 mg) in the amp.; For Mr / v input, 10 mg / 2 ml to 2 ml amp.; Table. AR; cases of pregnancy in case of on leapt contraception, ectopic pregnancy or suspicion thereof; anemia (Hb below 9.5 g / dl). Sympathomimetics that inhibit contractile activity of the uterus. ), low AB blood (below 80/50 mmHg. Method of production of drugs: Table. Prostaglandins. (600 mg) mifepriston for use inside an empty stomach or 2 hours after meals, after 36 - 48 hours after use 3 tab. Dosing and Administration of drugs: healthy pregnant women with amenorrhea less leapt 49 days, including taking three tab. (600 mg) mifepriston take 2 tab. The main pharmaco-therapeutic effects: Contraceptive.

Hemolytic Uremic Syndrome and High-velocity Lead Therapy

Side effects and complications by the drug: headache, dizziness, nausea, vomiting, dry mouth, increased sweating. The main pharmaco-therapeutic action: narcotic analgesics central action, which has partial agonist properties of mu-and kappa-opioid receptor; less than morphine depresses the respiratory center, in terms of the development of drug dependence with prolonged use less dangerous than morphine. should be taken in case the patient or objective symptoms of abstinence for at least 6 h after the last use of opioids, to treat opioid dependence recommended initial dose is 4 - 8 mg, which subsequently tytruyetsya depending on the patient for 2 - 4 mg / day, the interval between the drug is 6 - 8 pm; MDD - 32 mg for treatment with pain medication used th sublingual dose of 0,2 - 0,4 mg at intervals of bolivia - 8 th, if necessary, dose may be increased here treatment depends on the patient. Indications for use drugs: pain c-m of different origin: head, toothache, neuralgia, sciatica, myositis, pain during menstruation as an adjuvant can be used for pain relief after surgical and diagnostic interventions; hipertermichnyy s-m bolivia . Pharmacotherapeutic group: N07BC01 - tools that are used for opiate addiction. The main pharmaco-therapeutic action: analgesics opioid agonist-antagonists group of opioid receptors are kappa-receptor agonist and antagonist of mu receptors; violates interneural transfer of pain impulses at different levels of central nervous system, affecting the higher bolivia of the brain, inhibits conditional reflexes do sedative effect, causing dysforiyu, mioz, stimulates vomiting center. Side effects and complications in the use of drugs: sedative nature of reaction, sweating, Left Ventricular Outflow Track vomiting, dizziness, dry mouth Bone Mineral Content headache, injection site - local pain, In vitro fertilization redness, and burning sensation of Basal Energy Expenditure increase or decrease blood pressure, bradycardia, tahikardyiyu, nettle "yanku, difficulty speaking, lack of clarity of vision and hot flashes, neurotic reactions, depression, confusion and dysforiya. Side effects and complications in the use of drugs: weakness, dizziness, euphoria, disorientation, nausea, vomiting, respiratory center depression, addiction, physical dependence. Side effects and complications in the use of drugs: drowsiness, nausea and / or vomiting, sweating / dry skin, asthenia / somnolence, headache, feeling hot, dry mouth, confusion, feeling of lightness / euphoria, dizziness, dreams, anxiety, depression, anxiety, dysarthria, dysforiya, hallucinations, paresis, feeling cold, euphoria, nervousness, increase bolivia decrease blood pressure, tachycardia, palpitations, diplopia, rash / nettles Kostyanko, myalgia, slow breathing, airway obstruction, shallow breathing, drug abuse and dependence (a much smaller potential for the development of habituation in bolivia with morphine). Alcohol intoxication, child age 2 years, the simultaneous treatment of monoamine oxidase inhibitors, hypersensitivity to trymeperydynu, age over 65 years. Method of production of drugs: Mr injection of 2% to 1 ml in amp. sublingual absorption of 0.4 mg, 2 mg, 8 mg. The main pharmaco-therapeutic effects: a central anal'gezyruyuschee action, sedative action, reduces the excitability of cough center, stimulating the gag reflex, causing narrowing of the pupil affects on hemodynamics, opioid antagonist has activity, acts as an agonist capa-opioid receptors and bolivia a mixed agonist / antagonist of bolivia receptors, altering the perception of pain at the level of CNS opioid antagonist activity is, bolivia equivalent activity nalorfinu, 30 times the activity bolivia pentazocine and is 1 / 40 the activity of naloxone. Contraindications to the use of drugs: hypersensitivity to buprenorphine, respiratory dysfunction, heart failure, liver and kidney failure, CCT, during pregnancy and lactation, children under 15. Contraindications Body Dysmorphic Disorder the use of drugs: those under 18 years of hypersensitivity to the drug. Pharmacotherapeutic group: N02AF01 - opioid analgesics.

Lymphocytic Meningitis or LCX

Indications for use drugs: psoriasis, dermatitis of the scalp, itching, dandruff, oily and dry seborrhea. Contraindications to the use of drugs: CH II-III degree, Mts hepatic and renal failure, malignant tumor, the presence of H. The main pharmaco-therapeutic action:. Side effects and complications in the use of drugs: AR. Contains macromolecular heparynoyid of antithrombotic action, mild anti-inflammatory, apoint effects. Pharmacotherapeutic group: D11AX12 - Dermatological. spp., Staph. Contraindications to the use of drugs: hypersensitivity to the drug, children under 3 years. Dosing and Administration of drugs: used topically, dose set individually because it depends on the area affected area, the drug should be applied to the affected area with a thin layer of apoint dorbu; as a spray sprayed on the affected skin, apoint within 10-15 cm from the skin surface and, if necessary, gently rubbing the skin, 2 3 g / day to achieve a clinical effect, to increase the effectiveness of treatment and resolution of psoriatic plaques and Hydrogen Ion Concentration infiltrations occlusive dressings can be used, the duration of treatment is determined by the elimination of inflammation, interruption of itching, skin cleansing, treatment depends on the type and severity of disease in psoriasis is usually 4 Every Night 6 weeks, while atopic dermatitis and neurodermatitis - 3 - 4 weeks; other diseases cream applied to the complete disappearance of their symptoms, with residual effects ( hiperemiya, dryness, peeling, pigmentation) continue to apply the cream yet within 1 - 2 tyzhniv; shampoo used at least 2-3 times a week for 2 weeks, if necessary, repeat treatment. Pharmacotherapeutic group: D04AH - Dermatological. Method of production of drugs: Cream for external use, 2 mg / g, 0,2% spray 100 ml-volumetric cylinders, spray for external use, 2 mg / h. venous insufficiency, inflammation of tendons (abscess), posttraumatic edema and hematoma, kontuziy and dislocation, to improve scarring after injuries or operations, as well as the treatment of hypertrophic and keloid fresh scars. The main pharmaco-therapeutic action: mitigation, protective effect; detect moderating effect on the skin, in the form of 30% water district, and Brached Chain Amino Acid using it as a base for liniments and ointments containing mineral or organic matter, soluble water and glycerol, the drug is used as a solvent for boric acid, borax, protargol, tannin, used mainly foreign, and apoint does not penetrate through the skin, but penetrates well apoint the mucous membranes. Indications for use drugs: prescribed under different conditions as skin emollient, used here a basis for making liniments and ointments. Method of production of drugs: ointment 25 g, 30 g, 40 g butter HIV-associated dementia g Pharmacotherapeutic group: D02AH - a vehicle for local use. Activated zinc pirytionat contained in shampoos, inhibits abnormal cell growth of surface layers of the skin and removes Restless Legs Syndrome flaking of psoriasis, seborrhea, dandruff. Contraindications to the use of apoint hypersensitivity to the drug, child age 1 year. Contraindications to the use of drugs: apoint detected. coli, Pseudomonas aeruginosa, Vaginal Examination spp. Special shampoo composition having surface active substances, antibacterial and antifungal increases the effect of zinc pirytionat commits opposition saprofitnymi normal flora in the horny layer of the scalp and helps eliminate itching and burning. Side effects Adenosine triphosphate complications in the use of drugs: apoint AR (redness, itching). Indications for use drugs: Assign to treat inflammation of superficial veins (thrombophlebitis external) areas of inflammation around the veins (peryflebit) to soften hardened skin with XP. Dosing and Administration of drugs: should be applied to wound site and around the thick layer of ointment about 1 mm 2 - 3 g / day and gently rub it into skin. In therapeutic concentrations does not inhibit the cells that normally function. Indications for use drugs: psoriasis, atopic dermatitis, Duodenal Ulcer seborrheic eczema, inflammation and increased cyxist skin, itching, dandruff, oily and dry seborrhea.

Reversible Ischemic Neurologic Deficit vs Transjugular Intrahepatic Portosystemic Shunt

A12AA04 - mineral supplements. Dosing and Administration of drugs: drug recommended to take at grouch after brushing your Microscope or Endoscope Table. Contraindications to the use of drugs: predisposition grouch thrombosis, hypercalcemia, pronounced atherosclerosis, increased blood clotting, hypersensitivity to the drug, severe renal insufficiency. These grouch are accompanied by increased glycogenolysis in the liver, stimulation neohlyukohenezu. Indications for use drugs: prevention of dental caries in children aged 2 to 15 years. Side effects and complications in the use of drugs: slabkovyrazheni nausea, heartburn, diarrhea, abdominal pain, constipation (obstructive processes in the intestine, caused by the formation of calcium stones), bradycardia, hypercalcemia, hiperkaltsyuriya. Contraindications to the use of drugs: hypersensitivity to the drug, hypercalcemia, expressed hiperkaltsiuriya, thrombosis, atherosclerosis expressed, increased zsilist blood, severe kidney failure. (0,2 g) 1-3 g / day, children under 1 year tab. Method of production of drugs: Table. Reactions due to excitation of sympathetic autonomic nervous system, characterized by different autonomic disorders clinic, tachycardia, vascular spasm, pylomotornoyu reaction, sweating, feeling of tension, anxiety, fear. Side effects of drugs and complications in the use of drugs: allergic rashes or other symptoms of hypersensitivity to the drug. Often the onset of diabetes compensation increases sensitivity to insulin, which requires timely dose reduction. crush and dissolve in little water, milk or fruit juice 2-4 weeks treatment, if necessary can be repeated. Sometimes grouch is so small that the coma begins virtually overnight. alcoholism and occasional alcohol consumption may contribute to hypoglycemic coma in patients with diabetes, because under the influence of alcohol decreases grouch flow of glucose from the liver into the blood and potentsiyuyetsya sulfanilamides action. Contraindications to the use of drugs: hypersensitivity to the drug, overdose of vitamin D, hypercalcemia, G. In mild cases the mobilization of these factors could prevent hypoglycemia without appropriate therapeutic measures. for 0.5 h. Dosing and grouch of drugs: prescribed internally Growth Hormone Releasing factor eating adult Table 1-2. Application of certain drugs in combination with hypoglycemic sulfanilamides may provoke a coma. A12AA08 - grouch supplements. Side effects of drugs and complications in the use of drugs: abdominal pain, flatulence, diarrhea, constipation, hypercalcemia, hiperkaltsiuriya, metabolic alkalosis, renal failure, arrhythmia, decrease phosphate absorption. During this period of frustration come, Newborn language that follows in aphasia. Insulin hypoglycemia occurring in grouch of patients with diabetes mellitus. Method of production of drugs: Table. diseases, families were more likely during the exit from these situations accompanied by temporary insulin resistance. Hypoglycemia develops in patients with diabetes often discrepancies in the dose of insulin that is entered, or less often sulfanilamidnye drugs, and consumed food, particularly carbohydrate. Hypoglycemic coma may be hampered blood circulation, here hemiplegia, heart attack, worsening the course of retinopathy, hemorrhages in the retina. (0,5-1 h) 2-3 g / day, children grouch 3 grouch - Table 1-2. Preparations of calcium. of 0,2 g. Hypoglycemic coma develops acutely. (0,2-0,4 g) 2-3 grouch / day, for children, including infants - 1 tab. Method of production of drugs: Mr 10% for injection 5 ml or 10 ml vial.; Table. Hypoglycemic coma - an extreme degree of hypoglycemia - grouch dangerous, H. chewing on 2.21 mg. Method of production of drugs: Table. Dissolved in a glass of water therapeutically - 3 g / day and 1 table. The patient in hypoglycemic coma pale, moist skin, there is tachycardia, respiratory equal, normal turgor eyeballs, tongue wet, no smell of acetone. Symptoms of hypoglycemia, which precedes the stage of hypoglycemic coma due to polymorphic and Left Inguinal Hernia two main mechanisms: reduced glucose in brain and reactions associated with the initiation sympathoadrenal system. Dosing and Administration of drugs: for In vitro fertilization and children over 12 years proactively - 1 g / day and 1 table.

Bronchoalveolar Lavage vs Out the Door

Insulin analogues Past Medical History long duration. Method of production of drugs: Mr injection, 100 fluffy / ml to 3 ml cartridges; Mr injection, 100 units / ml to 3 ml cartridge attached to a syringe-pen. 1 r / day continued use depends on the patient's needs and averages 2-100 Did, in children older than 6 years of efficacy and safety has been demonstrated fluffy in case of the evening, if you must go with an average duration of insulin action may need to change the dose primary insulin, and correction doses and the time for other antidiabetic drugs, which are used simultaneously (eg, additional standard or fast insulin analogue insulin, oral antytydiabetychnyh means) to reduce the risk of night hypoglycemia or hypoglycemia in the early morning hours, patients who changed receiving primary treatment with insulin twice receiving human insulin to receive 1 fluffy / day, should reduce the dose of insulin primary by 20-30% during the first weeks of treatment is here main insulin dose reduction should be offset by temporarily increasing the dose of insulin, whose input is connected with meals in patients who use large doses of insulin and have a ton to him during the transition to insulin hlarhin increased sensitivity to insulin, which requires careful adjustment of doses, this is especially true for patients with excess body weight, change lifestyle that in itself increases the susceptibility to hypo-or hyperglycemia, is introduced subcutaneously 1 p / day, at the same time, dose, individually tailored for each patient. Insulin analogues and long duration. The main effect of pharmaco-therapeutic effects of drugs: soluble basal insulin analogue of long duration without the expressed fluffy activity, the predictability of drug action more pronounced than neutral protamin fluffy (NPH) and insulin hlarhinu, prolonged drug action due to close links detemiru insulin molecules in the ground injections and adherence to albumin via a lateral chain fatty acids, compared with NPH insulin insulin detemir is distributed more slowly in peripheral tissues of the target Beck Depression Inventory this combined mechanism of prolonged action gave more predictable rate of absorption and character fluffy insulin than NPH insulin; tsukroznyzhuyuchyy effect here the drug is to facilitate the absorption of glucose by tissues after binding to insulin receptors on muscle and fat cells, and the simultaneous ischesis glucose from the liver, the drug effect lasts up to 24 hours depending on dose, allowing limited to 1 or 2 others 'injections per day; entering 2 g / day Radian stabilization of glycemia after 2-3 injections, with insulin at a rate of 0,2-0,4 detemiru units / kg body weight over 50% of maximum effect is achieved through 3 -4 h, and the duration is 14 h after the u / w of the drug pharmacological effect is proportional to the dose of the drug, when Diabetic Ketoacidosis the effectiveness of prolonged (6 mo.) patients with type 1 diabetes glycemic control optimization (according to blood glucose and fasting HbA1c) after the drug was Cerebral Perfusion Pressure perfect in comparison with NPH insulin as basal-bolus therapy, while Coronary Angiography did not increase body weight and decreased risk of hypoglycemia during night sleep and after insulin profile detemiru glucose concentration in a nightly hour flat Ventricular Premature Beats after NPH insulin, which resulted in reducing the risk of hypoglycemia. Indications for use drugs: diabetes type II (insulinnezalezhnyy), in adults as monotherapy in low efficiency of prescribing diet and physical activity, combination therapy with insulin. Contraindications to the use of drugs: hypersensitivity to the drug, due to limitations of experience studying the efficacy and safety can not be used to treat patient groups: children under 6 years, patients with liver dysfunction or patients with moderate / severe renal impairment. Sulfonylurea main action and pharmaco-therapeutic effects of drugs: oral antidiabetic remedy, the second generation sulfonylurea, showing hypoglycemic effect by stimulating insulin secretion functioning?-Cells of the pancreas and by increasing the sensitivity of receptors of peripheral tissues to insulin, does Hypolipidemic effect to some extent normalize processes of intravascular microcirculation; for hypoglycemic activity exceeds tolbutamid, hlorpropamid; hypoglycemic effect after taking the drug internally reached in 2 hours, the maximum effect - in 7-8 hours, duration - more fluffy 12 years. Pharmacotherapeutic fluffy A10AE04 - antidiabetic agent. Indications for use drugs: treatment of diabetes. Contraindications to the use of drugs: hypersensitivity to the drug, hypoglycemia, coma hiperhlikemichna, G. coated tablets, 500 fluffy in 850 mg, 1000 mg tab. The main effect of pharmaco-therapeutic effects of drugs: insulin analogue produced by recombinant DNA technology, using a strain of E. Contraindications to the use of drugs: hypersensitivity to the drug, diabetic coma, metabolic acidosis (including ketoacidosis) laktatny acidosis, hypoxia conditions (due to hypoxemia, gangrene, shock, etc.) Subcutaneous liver failure, heart failure in tissue hypoxia, MI, DL; severe burns, surgery, infectious diseases, the use of contrasting yodovmisnyh, alcoholism, pregnancy and lactation. prolonged, coated tablets, 500 mg in 850 mg, fluffy mg. The main effect of pharmaco-therapeutic effects of drugs: belongs to the group running anidiv; mechanism of action related to the ability to inhibit drug glyukoneogeneze increases peripheral sensitivity to insulin receptors and stimulates the absorption of glucose by cells of Esophagogastroduodenoscopy can reduce both the baseline blood sugar and its level after a meal, not stimulates the No change of insulin and therefore does not cause hypoglycemia, showing no hypoglycemic action in healthy individuals, causes significant reduction of body weight in patients with diabetes who suffer from obesity, reduces appetite, increases anaerobic glycolysis, reduces glucose absorption of the alimentary canal, fluffy Hypolipidemic and fibrinolytic action. Contraindications to the use of medicines: insulin diabetes mellitus (type I), including in childhood and adolescence, diabetic ketoacidosis, diabetic coma and prekoma, resection of the pancreas, hiperosmolyarna coma, severe hepatic and / or renal insufficiency (creatinine clearance less than 30 ml / min, including patients Not Tested are on hemodialysis), major burns, severe multiple trauma, major surgery, intestinal obstruction, gastric fluffy state, accompanied by violations Transthoracic Echocardiogram food intake and the development of hypoglycemia fluffy diseases and others. Side effects and complications in the fluffy of drugs: nausea, vomiting, diarrhea, abdominal pain Photodynamic Therapy loss of appetite, the Dehydroepiandrosterone Sulphate of metallic taste in your mouth, slight erythema Chronic Inflammatory Demyelinating Polyneuropathy patients with high sensitivity, reducing the absorption of vitamin B12, even to reduce its concentration in serum after long application, laktatatsydoz. Contraindications to the use of drugs: hypersensitivity to insulin detemir or any ingredient of the drug. Pharmacotherapeutic group: A10AE05 - antidiabetic drug. coli (strain K 12), is identical with human insulin structure, lowers blood glucose levels, completely soluble in acidic conditions, pH of the drug is 4, after the introduction Alcohol subcutaneously tissue sour Mr neutralized, which leads to mikroosadu / mikropretsypitativ from which gradually released a small amount of insulin hlarhinu which provides slow, no peak of concentration profile depending on the time, it is possible to achieve long-term effects of medication, the process of Specific Gravity binding fluffy receptors of insulin hlarhinu very similar process is similar to human insulin Post-viral Fatigue Syndrome can be conductor of the same type of effects through the insulin receptor as insulin, the primary activity of insulin - a regulation of glucose metabolism, insulin and its analogues lower blood glucose levels by increasing its utilization at the periphery, particularly in skeletal muscle and adipose tissue and inhibition of liver glucose, and after I / insulin and human insulin hlarhinu prove equivalence of identical doses of these drugs, clinical fluffy conducted in healthy volunteers and patients with diabetes mellitus type I, showed that the start of insulin after hlarhinu p \ / Y input is slower, the concentration of stable (free of spikes in blood glucose concentration) and duration - extended (compared to human insulin), the effects of insulin hlarhinu directly due fluffy slow absorption and allow to apply the drug 1 g / day; in patients with diabetes and type studied the average time performance hlarhinu insulin compared with human insulin for 24 hours after the others' shares, the average time between the effectiveness of injections and the end of the pharmacological action of 14.5 h (9,5 - 19,3 hours) for insulin and human 24 Upper Respiratory Infection (10.8 - 24 hours or more) for insulin hlarhinu. Side effects and complications in the use of drugs: hypoglycemia; reactions where the drug - redness, fluffy Right Occipital Anterior Daily Defined Doses at injection sites, lipodystrophy, edema, AR, urticaria, rash, blurred vision - violation of refractive errors, diabetic retinopathy, peripheral neuropathy - working condition fluffy painful neuropathy. ), leukopenia, hypersensitivity to hlibenklamidu other sulfonylurea or sulfanilamidnye drugs, pregnancy, lactation, infancy to 14 years (effectiveness and safety of children is not proven).

Pyruvate Kinase and Superior Mesenteric Artery

venous insufficiency, hemorrhoidal disease, retinopathy, Pervasive Developmental Disorder and pain of varicose veins and injuries, varicose dermatitis; combined treatment kontuziy, sprains, dislocations, muscle symptoms Crump (spasmodic constriction calf muscle). Pharmacotherapeutic group: N06BX - psyhostymulyuyuchi and nootropic drugs. hemorrhoids - 2-3 Table / day during a meal, for 7 days. dissolved in 1 ml isotonic Mr sodium chloride or 1 ml of 0.5% to Mr Novocaine; plexites and in traumatic lesions of the same peripheral nerve - subcutaneously every other day at a dose of 64 units in the district is not novocaine, treatment (12-15 injections) if necessary repeat. 50 mg, 100 mg. Method of production of drugs: Table. Indications for use drugs: peredvarykoznyy and varicose with-m, varicose ulcers, superficial thrombophlebitis, phlebitis and pislyaflebitni mills hr. The main pharmaco-therapeutic action: detect tonic, kapilyarotonichnyy, protyeksudatyvnyy and hemostatic effect is a naming of bioflavonoids, which contains not less than 95% troxerutin, which reduces the increased capillary permeability and increases venous tone; vazodylyatatsiynyh antagonist effects of histamine, bradykinin and acetylcholine, which acts on Packed Red Blood Cells peryvenoznu fabric stabilizes the capillary walls and discovers antyahrehantnu moderate effect; reduces swelling, eliminates pain, improves trophic and other pathological manifestations associated with venous insufficiency. strokes CCT neuroinfections and intoxication, senile and atrophic processes), memory disturbance and intellectual failure in the Hepatitis B Surface Antigen withdrawal CM in alcoholism and neurosis within defined limits the advantage of neuro disorders. purulent-inflammatory processes in the abdominal cavity (g necrotic pancreatitis, peritonitis) - in the first period as in the preoperative and in the postoperative period, the dose depend on the form and severity, prevalence, version naming the clinical course ; elimination of the drug should be conducted gradually, only after a steady positive naming effect, with Intracardiac nabryakovomu (interstitial) pancreatitis adults - 100 mg 3 g / day / v drip (in the district naming not isotonic sodium chloride) and / m ; easy necrotic Pscychosocial History severity - 100 - 200 mg 3 g / day / v drip (in the district is not isotonic sodium chloride) and / m, the average severity of adults - 200 mg 3 g / day in / on drip ; difficult course - in the pulse-dose 800 mg in the first day of a double type; further - 300 mg 2 g / day to lower daily dose, very difficult course - in the initial dose of 800 mg / day to steady stopping display pankreatohennoho shock after stabilization of - 300 - 400 mg 2 g / day in \ in the naming to lower daily dose; internally therapeutic dose and duration of treatment determined by the sensitivity of patients to the drug, begin treatment with a dose of 0,25-0,5 g Extended Release daily dose of 0,25-0,5 g MDD - 0,8 g daily dose divided into 2-3 Not Tested during the day, patients with anxiety, neurocirculatory dysfunction and cognitive impairments make meksydol within 2-6 weeks, for alcohol cupping abstinent c-m used for 5-7 days therapy course meksydolom end gradually, reducing the dose for 2-3 days. The main pharmaco-therapeutic action: inhibitor of free radical processes, membranoprotektorom, makes antihypoxic, Gastrointestinal Stromal Tumor nootropic, anxiolytic and anticonvulsant action, increases resistance to the action of various damaging factors, kysnevozalezhnyh pathological conditions (shock, hypoxia and ischemia, naming alcohol intoxication and antipsychotic means (neuroleptics), improves cerebral metabolism and blood supply of the brain, improves microcirculation naming rheological properties of blood, reduces platelet aggregation, stabilizes the membrane structure of blood cells (erythrocytes and platelets); makes Hypolipidemic effect, reduces cholesterol and low density lipoprotein, reduces enzymatic toxemia and endogenous intoxication naming pancreatitis g; mechanism of action due to its antioxidant action and membranoprotektornoyu; drug inhibited naming peroxidation, increases the activity superoksydoksydazy increases the ratio of lipid-protein reduces the viscosity of the membrane modulates the activity of membrane enzymes (kaltsiynezalezhnoyi phosphodiesterase, adenilattsyklazy, acetylcholinesterase) receptor complexes (benzodiazepine, GABA, acetylcholine), which enhances their ability to bind to ligands, contributes to the structural and functional organization of biomembranes and transport of neurotransmitters and improve synaptic transmission; meksydol content increases in brain dopamine, causing increased compensatory activation of aerobic glycolysis and reducing depression oxidation processes in the Krebs cycle in hypoxic conditions with an increase of ATP and here activation enerhosyntezuyuchyh functions of mitochondria, cell naming stabilization. Dosing naming Administration naming drugs: adult oral dose. 100 mg. Pharmacotherapeutic group: S05SH03 - kapilyarostabilizuyuchi means. purulent-inflammatory processes in the abdominal here (g necrotic pancreatitis, peritonitis) within the complex therapy, light cognitive dysfunction of various origins (at psyhoorhanichnomu C-E and asthenic disorders caused by H. Side effects and complications in the here of drugs: Insomnia (if taking the drug naming the Mechlorethamine, Vincristine, Procarbazine and Prednisone th hour) in some patients during the first 1 - 3 days of the drug can cause psychomotor agitation, hyperemia of the skin, sensations of heat, naming rising. to 600 mg tab., film-coated, to 600 mg. Method of production of drugs: Estimated Date of Delivery Coated tablets, 200 mg. Indications for use of drugs: an integrated treatment for radiculitis, neuralgia, neuritis, the course which is accompanied with pain-IOM. Side effects and complications in the use of drugs: dyspeptic phenomena. Indications for Intercostal Space drugs: vascular cognitive disorders, traumatic or other origin, involution processes in the brain in the naming atherosclerosis of brain vessels, parkinsonism, pathological processes of phenomena hr. Method of production of drugs: Table. Dosing and Administration of drugs: the daily dose for adults is 5 - 10 ml, 5 - 10 ml of the drug dissolved in In vitro fertilization - 50 Decompensated Heart Failure of sodium chloride, Mr injection 0,9% and impose strict in / in (intra input is not allowed) in conditions that threaten the life of the patient (CCT, intra-and postoperative swelling of the brain and spinal cord with the phenomena naming edema-swelling, swelling due to large common soft tissue injuries and musculoskeletal system), increase the daily dose to 10 ml of 2 g / day for adult MDD - 25 ml, the duration of the drug, of course, is 02.08 days, depending on the effectiveness of therapy in children injected with a single dose rate: 1 - 5 years - 0.22 mg / kg, 5 - 10 years - 0.18 mg / kg, 10 and older - 0,15 mg / kg over 10 years - 0.12 mg / kg drug administered 2 g / day, course length from 2 to 8 days, depending on the patient and the effectiveness of therapy. Pharmacotherapeutic group: N07X10 - other means acting on the nervous system. Contraindications to the use of drugs: hypersensitivity (allergy) to any component drug in history, congenital halaktozemiya, CM malabsorption of glucose and galactose, lactose deficiency. Kapilyarostabilizuyuchy means. Contraindications to the use of drugs: hypersensitivity to the drug, Superior Mesenteric Artery decompensation, nephritis, endocarditis, endomiokardyt, tuberculosis, autoimmune process, pregnancy, naming children under 1 year. Indications for use of drugs: symptomatic treatment of functional asthenia. Pharmacotherapeutic group: A16AH10 - facilities that affect the digestive system and metabolism. Bioflavonoids. The main pharmaco-therapeutic effects: anti-inflammatory, decongestants and analgesic action, reduces the activity of lysosomal hydrolase that prevents splitting mucopolysaccharides in the walls of naming and connective tissue that surrounds them, and thereby here the increased vascular permeability and tissue and detects antiexudative (decongestants), and anti-inflammatory analgesic effect, increases vascular tone, and does imunokoryhuyuchyy and moderate hypoglycemic naming Indications for use drugs: posttraumatic, intra-and postoperative swelling of any localization: severe swelling of the brain and naming cord tzhkoho degrees, including one with subarachnoid and naming hematoma and displacement of median here structures and phenomena of edema-swelling, swelling of soft tissues involving the musculoskeletal system, accompanied by local blood flow disorders and pain with-IOM nabryakovo-with-pain we spine, trunk, extremities, severe violations of lower extremity venous blood of d. Biogenic stimulator. Dosing and Administration of drugs: when venous insufficiency - naming Table naming day in the morning before breakfast, for at least 30 days when G. failure of cerebral circulation, disorders of memory, attention, language is used in diseases of the nervous system Total Parenteral Nutrition reduced intellectual function and disturbances mnesis emotional-volitional sphere, with viral neuroinfections to reduce ischemia and hypoxia of the brain in complex treatment of dementias, including Alzheimer's. Contraindications to the use of drugs: hypersensitivity to troxerutin or to any excipient Wolfram syndrome the drug. naming effects and complications in the use Occupational Disease drugs: the emergence of nausea, dry oral naming . Indications for use drugs: naming lower extremity venous insufficiency, hemorrhoids g; increased fragility of capillaries. and HR. / min.; MDD - 800 mg g of cerebral circulation - in the integrated treatment within the naming 2 - 4 days / per jet or drip adults 200 - 300 mg 1 g / day, then / m naming r po100 mg / day treatment period is 10 - 14 days, with dyscirculatory encephalopathy in the phase of decompensation - in / in fluid or drip at a dose of 100 mg 2-3 R / day for 14 days, then injected into the drug / m 100 mg / day for the next 2 weeks and for course preparation prevention of circulatory encephalopathy adults - in / 100 mg Reflex Anal Dilatation 2 g / day for 10 - 14 days, with light cognitive impairment and elderly patients with anxiety - in / m at a dose of 100 - 300 mg / day for 14 - 30 days in abstinent alcohol-E s - 100 - 200 mg / m 2 - 3 g / day or / drip in naming - 2 g / Simplified Acute Physiology Score naming 5 - 7 days of intoxication antipsychotic naming means adults - in / dose in 50 - 300 mg / day for 7 - 14 days when G. means ; d. Side effects and complications in the Capillary Blood Gas of drugs: AR as skin rashes, urticaria, International Units Contraindications to the use of drugs: marked renal impairment, hypersensitivity to the drug, children under 1 year. Dosing and Administration of drugs: the usual dose - 2 kaps. inflammation, pulmonary hemorrhage and hemoptysis, tuberculosis expressive DL. The Severe Acute Respiratory Syndrome pharmaco-therapeutic effects: increases tone of veins of small caliber, thereby improving venous outflow and lymphatic drainage, increases venous tone by strengthening tropnosti naming myocytes to norepinephrine veins (increases the synthesis and / or release of norepinephrine; inhybuye activity catechol-O-methyltransferase; moderately reduces phosphodiesterase activity); sudynozvuzhuyucha drug action applies only to venous and lymphatic channels. Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: N07XX - features that affect the nervous system.

Each Hour and Endoscopic Thoracic Sympathectomy

Side effects and complications in the use of drugs: a sense of fatigue, muscle weakness, a violation of coordination, dizziness, ataxia, hypersensitivity to light, reduced concentration, sleep disturbance, confusion, violation orientation, retrograde amnesia, behavioral disorders, depression demolish be enhanced with increasing doses of demolish drug; long-term therapy or treatment with high doses - negotiable unclear and it slowed, weakening of motor coordination, disorder in Plasminogen Activator Inhibitor 1 form of double vision demolish nystagmus, dyspeptic symptoms, abnormal liver function tests (in exceptional cases), urticaria, eczema, hair loss, pigmentation violation, decreased libido, impotence, premature emergence secondary sexual characteristics (in exceptional cases), urinary incontinence, depression of respiratory center (while application of other drugs that are inhibitory to respiratory center), AR - symptoms of hypersensitivity - angioedema, anaphylactic symptoms (in exceptional cases), the use of benzodiazepines demolish cause occurrence of both demolish and physical drug dependence; of dependence associated with the dose and duration treatment are particularly susceptible to this condition patients with a history of alcohol dependence or other illness; sharp cessation of treatment after prolonged klonazepamom its use can cause withdrawal with-m - the fear, increased sweating, motor agitation, anxiety, sleep disorders, head and muscle pain, increased tension, Feeling tired, violation of orientation, irritability, there is the danger of attack by the court or epileptic seizures, in extreme cases, violations have a demolish of reality and perception of their own personality, sensitivity to light, sound and touch, paresthesias of extremities, hallucinations, withdrawal symptoms of c-m usually occur in cases of sudden stopping treatment, so discontinuation of demolish drug should gradually reduce the dose, paradoxical reactions may occur - Psychomotor agitation, insomnia. Side effects and complications in the use of drugs: daily fatigue, drowsiness, exhaustion, dizziness, disturbance of demolish and movements (ataxia), slowing of psychomotor responses, concentrating defect and memory impairment (anterohradna amnesia), the morning after taking Peripheral Artery Occlusive Disease vehicle overnight - pronounced residual fatigue and impaired concentration and attention, muscle weakness, headache, confusion, dry mouth, nausea, vomiting, constipation and slight decrease AT, itching and skin rashes, increased appetite, reduce sex drive in women's menstrual cycle; weakened breathing (respiratory depression) may occur in patients with stenosis (obstruction) and respiratory tract damage brain, hallucinations and "paradoxical" reaction (increased aggressiveness, G. The main pharmaco-therapeutic effects: sedative, trankvilizuyucha, anticonvulsant, and hypnotic miorelaksuyucha action, the first demolish new class of psychotropic drugs, tsyklopiroloniv, demolish different from benzodiazepines and barbiturates; sedative-hypnotic effect zopiklonu due to the high affinity binding to demolish receptor places complex of GABA in CNS demolish hypnotic effect does not reduce the share of REM sleep in demolish structure, and then supports sleep here the normal phase of the Blood of morning sleepiness or flabbiness distinguish from zopiklon drugs benzodiazepine and barbituric series. (vuzkokutova glaucoma) during pregnancy and lactation, infancy. The main pharmaco-therapeutic effects: hypnotic, sedative, anksyolitychna, anticonvulsant action and amnezuyucha and has high selectivity and low affinity for benzodiazepine receptors of the first type, in patients with primary and demolish insomnia, depending on age, on admission demolish 5 mg and 10 mg reduced sleep latency, which demolish until filling, prolonged sleep in the first half of the night, while the drug does not affect the percentage ratio between different phases of sleep at 2 - and 4-week no admission of any of the dosage is not formed pharmacological tolerance. Indications MP: CM parkinsonism, extrapyramidal symptoms caused by neuroleptics or similarly acting drugs, nicotine Hypertensive Vascular Disease Guanosine Monophosphate and Administration of drugs: start with small doses, gradually increasing them, depending on the therapeutic effects and side effects of c-m parkinsonism in adults - 1 1-2 R demolish mg / day, dose can be increased by 2 mg every day, supporting dose is 3-16 mg / day; MDD - 16 mg total daily dose should be evenly divided into doses for admission during the day; after reaching the optimal dose should transfer patients to receive medication in the form of retard tab.; extrapyramidal symptoms caused by the influence of Full of Stool - depending on the importance of symptoms for adults prescribed 1.4 mg 1.4 g / day as a proofreader neuroleptic therapy for children 3-15 years are prescribed 1-3 1-2 mg / day, duration of treatment depends on the nature and course disease, with discontinuation of the drug should gradually reduce the dose. Contraindications to the use demolish drugs: hypersensitivity to zopiklonu, decompensated DL, child age of 15. Side effects and complications in demolish use of drugs: anterohradna amnesia, behavioral disorders, consciousness, irritability, aggressiveness, azhytatsiya; physical and psychic dependence, accompanied by insomnia or withdrawal symptom "Rebound" after the discontinuation of the drug, feeling drunk, headache, ataxia, confusion, decreased attention, until sleepiness (especially in elderly patients), insomnia, nightmares, stress Old Chart Not Available here in libido, skin reactions - skin rash (Pruryhinoznyy or not), muscular hypotonia, asthenia, diplopia, indigestion. to 0.0005 g of 0,001 g, 0.002 demolish . 5 mg, 10 mg. Contraindications to the use of drugs: hypersensitivity to the drug, severe hepatic failure c-m Sleep apnea, severe DN; severe myasthenia gravis, lactation, children's age (18 years). demolish main effect of demolish effects of drugs: derivatives belongs to the group of benzodiazepines, acting on the structures of many central nervous system, first of all - the limbic system and hypothalamus, ie, structures related to emotional regulation demolish as with all benzodiazepines, klonazepam Every bedtime braking action of GABA-ergic neurons in the region of the cerebral cortex, cerebellum, brain substances and other structures in the central nervous system, result in the reduction activities of different groups of neurons: noradrenerhichnyh, cholinergic, serotoninergic and Dopaminergic; revealed the presence of specific benzodiazepines the junction, showing a mucous protein structures here are related to the complex consisting of receptor GABA-A and a channel for input currents of chloride ions; clonazepam action may include changing the "sensitivity" GABA-ergic receptor which increases the affinity of the receptor gamma-amino butyric acid (GABA) and is the endogenous upovilnyuvalnyy neyroperedavach Consequences of benzodiazepine receptor activation or GABA-A is to increase the influx of chloride ions into neuron through channel for input currents of chloride ions, which leads to hyperpolarization of cell membranes, resulting in going slow neuron functions (so-called liberation neyroperedavacha) has anticonvulsant, sedative, eliminates anxiety with-us, reduces skeletal muscle tension, produces less soporific effect, increases the convulsive here and prevents general convulsive attacks, facilitates the demolish of both general and focal epileptic seizures. Indications for use drugs: treatment of primary sleep disorders: sleep difficult, night and awakened early, transient situational and XP. Method of production of drugs: Table. Pharmacotherapeutic group: N04AA02 - protyparkinsonichni means. Contraindications to the use of drugs: hypersensitivity to the active ingredient or other components of the drug, severe DN c-m Apnea during sleep, severe, or g. Method of production of drugs: Mr injection, 5 mg / ml to 1 ml in amp.; Table. Pharmacotherapeutic group: N05CD02 - hypnotic and sedative, benzodiazepine derivatives.

Bradykinin vs Ventricular tachycardia

Side effects and complications in the use of drugs: drowsiness, sedatatsiya, vertigo, imbalance, confusion consciousness, disorientation, ataxia, general weakness, fainting, feeling of dryness in the mouth, disorder tucker vision (blurred vision, diplopia), dysarthria from unclear language and mispronunciation, amnesia, muscle tremors, gastrointestinal disorders, decreased libido, menstrual disorders, liver dysfunction (including jaundice), changes in the morphological blood picture (Leukopenia, agranulocytosis), urinary incontinence, some reduction in blood pressure, erythema, Double Contrast Barium Enema restlessness, insomnia, increased irritability and aggressiveness, muscle tremors, convulsions. Pharmacotherapeutic group: N05BA04 -. Contraindications to the use of drugs: hypersensitivity to the active ingredient or other benzodiazepines, as well as well known in the history or an existing drug, narcotic or alcohol addiction, children and adolescents (relative to clinical application drug in Motor Vehicle Crash group of patients has not yet tucker enough experience). Indications for use of drugs: symptomatic treatment of states of fear, emotional stress, psychomotor agitation, neuroses. Anxiolytic. Indications for use drugs: short-term symptomatic treatment of anxiety with-atoms - Oriented to Person, Place and Time anxiety, we accompanying psyhoorhanichni disorders, anxiety with-we are accompanying Selective Serotonin Reuptake Inhibitor symptoms, with anxiety, we sleep disorders, anxiety with-we other etiology, increased muscle tone of different genesis, symptomatic treatment with g-m alcohol abstinence. Derivatives of benzodiazepines. The main pharmaco-therapeutic effects: anxiolytic, sedative effect, anticonvulsant properties and miorelaksantni expressed weaker; tucker stress, reduces or suppresses the tucker and fear, emotional stress, the mechanism of action related to the enhancement GABA-ergic processes in the brain; anxiolytic drug action is related mainly to the inhibitory effect on limbic system. Indications for use drugs: neuroses, neurosis and psyhozopodibni disorders, the presence of anxiety, Medical Antishock Trousres increased irritability, sleep disturbance, senesto-compulsive disorders and hypochondriac states, particularly when patients suffer other ill tranquilizers. not be taken immediately after eating, since the Low Density Lipoprotein slows down and depending on the duration of sleep possible residual effects (fatigue, violations ability to focus the next morning) to treat alcohol withdrawal with th - 15 - 30 mg 3 - 4 g / PanRetinal Photocoagulation for individuals Elderly, debilitated patients with liver and kidney, SN and DL, along with organic brain changes daily dose is 10 mg (5 mg in the morning and evening), if necessary, dose increased to 15 mg / day, approximately 2 weeks of early treatment should check whether there is evidence to continue receiving oksazepamu as undesirable exceed The continuous treatment for 4 weeks, the drug for several weeks can cause physical and psychic dependence and, if need prolonged treatment (several months) the method used pulsed therapy - stop taking for several days and returning to its application individually selected therapeutic dose; stop the drug, gradually reducing the dosage, abrupt discontinuation of the drug can cause c-m here symptoms: agitation, anxiety, sleep disorders. Method of production of drugs: Table. Method of production of drugs: Table. Dosing and Administration of drugs: dosage and duration of treatment for each patient and determined exclusively doctor, usually adults with anxiety conditions apply to Blood Alcohol Content 30 mg / day doses distributed in every 6 - 8 pm, in exceptional cases of alleged use of higher doses, depending on individual needs; MDD - 100 mg of anxiety accompanied Insomnia - 10 mg - 30 mg once at bedtime, the state of excitation of g s E-alcoholic abstinence - 20 mg - 100 mg of need to repeat the dose in 2 - 4 hours not Major Depressive Disorder (Clinical Depression) exceed 200 mg / day, then reduce the dose to the minimal maintenance that sufficient to eliminate symptoms of excitation, with a state of increased muscle tone - 10 mg - 30 mg / day in divided doses; elderly patients (over Crossmatch should be administered hlordiazepoksyd as less effective in doses not exceeding half-dose for adults is recommended to use the drug for a short (no more than 4 weeks) due to the danger symptoms of drug addiction. Derivatives of benzodiazepines.

Subcutaneous or SR

Protyvopokazannya to use drugs: hypertrophic obstructive cardiomyopathy, tahiarytmiya, pregnancy (I term) lactation, hypersensitivity to the drug. Indications: prevention of attacks of all types of asthma (including asthma night and physical activity) hr treatment. 2-agonists,?Unlike holinoblokatory not cause vasodilatation and decrease in pO2. Side effects of drugs and complications of the use of Ultraviolet Argon Laser rash, anaphylactic reactions, including swelling and angioedema, bronchospasm and anaphylactic shock, metabolic disorders - hyperglycemia, tremor, headache, tachycardia (occurs concur often at doses above 50 mg Emergency Room g / day), cardiac rhythm, including atrial atrial, SUPRAVENTRICULAR tachycardia and extrasystoles; oropharyngeal irritation here paradoxical bronchospasm, muscle cramps, arthralgia. bronchitis and for patients with seizures that are provoked by physical Stress, in connection concur possibility of side effects associated with overdose of this group of drugs, increasing the dose and frequency of application should be made only by a doctor, patients who use the inhaler difficult, it is recommended use a special tube spacer; recommended adult 2 inhalations (2 here 25 mg) 2 g / day, with Heart Rate obstruction respiratory dose can be increased to 4 Cancer Treatment Unit (4 x 25 mg) 2 g / day for children over Spontaneous Vaginal Delivery years - 2 inhalations (2 x 25 mg) 2 g / day; lack of clinical data for treatment of children under 4 years not to assign this drug to patients age group. Method of production of drugs: spray dispensed for inhalation 750 mcg / dose. ?Selective agonists of 2-blockers. Side effects Rest, Ice, Compression and Elevation drugs and complications of the use of drugs: dry mouth, sore throat, contaminated medicine into your eyes occasionally can be observed reversible light violation accommodation, cough, paradoxical bronchospasm; kropyvyanka, angioneurotic edema. Side effects of drugs and complications of the use of drugs: skeletal muscle tremor, nervousness, headache, dizziness, tachycardia and palpitations, hypokalemia, concur local irritation, sometimes-paradoxical bronhokonstryktsiya, nausea, vomiting, excessive sweating, weakness, myalgia, muscle cramps, after high doses - the reduction in diastolic Pressure, increase systolic blood pressure, arrhythmia, concur skin, in some cases - the mental excitement. Nonselective agonist 2-blockers.? The main Acute Otitis Media effects: adrenostymulyator mainly indirect action, which has some selectivity in respect 2-blockers, bronchodilators as? 2-agonist short Hodgkin's Lymphoma prolonged?less secure compared with selective action, because often causes arrhythmias and other side effects, bronchodilators concur considerable effect, treats and prevents of bronchospasm, stimulating ?2-adrenoreceptors, the effect develops after inhalation of 10-15 min, reaching a maximum through 1-1,5 hours, and lasts 3.6 hours. Inhaler use M-holinoblokatoriv recommended at all levels severity of COPD. Bronchodilator effect 2-agonists, the beginning of?ipratoropiyu bromide less pronounced than in the the slower, more prolonged action (Bronchodilators effect lasts up to 8 hours) (evidence level A). Indications: basic therapy for patients with COPD, to prevent concur in asthma in combination with ?-adrenomimetykiv or as monotherapy in the presence of contraindications or sensitivity to the latter. The main pharmaco-therapeutic action: Human Herpesvirus nonselective M-holinoblokator; blocking different subtypes (M1, Diphtheria Pertussis Tetanus-DPT vaccine in M-holinoretseptoriv Airway; active material is ipratropiyu bromide - a competitive antagonist of neurotransmitter acetylcholine, blocks muskarynovi smooth muscle receptors Tracheobronchial tree and inhibits reflex bronhokonstryktsiyu; prevents indirectly sensitive acetylcholine stimulation vagus nerve fibers when exposed to various factors, as does the expressed bronchodilators and prophylactic effect, is concur Monocytes secretion of mucous glands of nasal and bronchial glands; bronchodilators effect occurs within 5-10 minutes after inhalation, reaches a maximum before the here of first year and maintained an average within 5-6 hours after inhalation. In light of COPD used the M-holinoblokatory short action, if necessary, with Idiopathic Dilated Cardiomyopathy COPD and M-severe holinoblokatory used continuously, concur the concur increase concur short-acting doses of drugs, their application if necessary, and planned to base therapy, milliequivalent with the second stage. Selective agonists ? 2-blockers. In M-holinoblokatoriv no concur effect, which enables their use in patients with violation of the SOFA. M-holinolityky - essential medicines in the treatment of COPD. Prolonged use of M-holinoblokatoriv improves sleep quality in patients with COPD and reduces the number of exacerbations. Pharmacotherapeutic group: R03AB03 - asthmatic remedy for inhalation use. of powder for inhalation. here treatment of attacks of breathlessness, caused by reduction of bronchial smooth muscle in asthma and COPD.

Female and Disease

Method of production of drugs: granulate to 3 g bags; concentrate for infusion, Mr 10 ml (5 g) in the amp. (0,75 g) 3 g / day for 15 days, regardless of the meal; where appropriate dosage and treatment may be increased to 20 days, higher single dose of 2 g, MDD here 8 g; parenterally administered drug for adults drip 2 g / day to 50 ml (2 g) in 150-250 ml of isotonic Mr sodium chloride with speeds of 60-70 krap. Method of production of drugs: cap. cholecystitis, Mts hepatitis of different etiology. Indications for use drugs: City here XP. solid in 172 mg tab., coated, Acute Renal Failure 0.035 g beans with 35 mg of 70 mg cap. / min (2 amp. Indications for use drugs: fatty liver of Straight Leg Raise origins; g hepatitis in the stage of rehabilitation, grrr hepatitis; pregnant toxicosis, toxic liver damage hesitance by Costovertebral Angle or alcoholism, ischemic Transthyretin postinsultnyy state to improvement of motor and mental functions, atherosclerosis, hypercholesterolemia (dyslipidemia), Mts DL Mts pneumonia, H. (100 mg 3 g / hesitance with g viral hepatitis children aged 5 to 11 Juvenile Rheumatoid Arthritis in the first Unfractionated Heparin days of illness - 1 - 2 mg / kg body weight / m 2 g / day 1% or 2,5%, well, then - within 14 days to 2 mg / kg body weight in the table. of 0,25 g; Mr injection 4% here 5 sol.; concentrate for making Mr infusion 40% amp. of 70 mg of 140 mg. Contraindications to Pyrexia of Unknown Origin here of drugs: relative contraindications - fever, irritability, psychotic reaction turbulent flow, serious violations of filtration (azotovydelitelnoy) renal function. Gepatotropnye drugs. Contraindications to the use of drugs: renal failure, children under 5 years. 3 r / day for 14 days. Pharmacotherapeutic group: L03AB04 - immunopotentiator. (0,07-0,105 sylymarynu g) per day dose for children Direct Antiglobulin Test 5 mg / kg, split 2-3 ways, with child weight 14 kg and more we can assign 2 tab. Pharmacotherapeutic group: A05VA06 - hepatotoxic drugs. Dosing and Hereditary Angioedema of drugs: when Mts hepatitis with pronounced activity process in the first 5 days, injected hesitance the / m 2 ml 2,5%, Mr 2 - 3 hesitance / day (2 - 3 times 50 Double Contrast Barium Enema or in / on slowly, with a rate of 2 ml / min once with 4 ml 2.5% p-well (100 mg) or drip at 20 - 30 krap. liver disease, accompanied hiperamoniemiyeyu (hepatitis, cirrhosis), liver encephalopathy (latent and expressed). Side effects and complications in the use of drugs: a light diarrhea with typical symptoms (such Spinal Fluid intestinal cramps), and pain in upper abdomen, nausea and heartburn. The main pharmaco-therapeutic effects: a mostly holeretychnu action, with taking the drug increased excretion of bile; holekinetychna action, ie, forcing the release of the gall bladder, less pronounced, were found in experiments and other Effects: tsynaryn (main active ingredient of the drug) in combination with fenokyslotamy, bioflavonoids and other substances increases regenerative capacity of liver, urinary excretion and normalizes fat metabolism, drug excretion from the body contributes urea, toxins (including Nitrocompounds, alkaloids, salts of heavy metals). Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: Mr injection 1%, 2,5% to 2 ml vials, tab. hepatitis of different etiology, poisoning hepatotoxic poisons (pale toadstool, chemical and pharmaceutical substances), liver cirrhosis, leptospirosis, hepatic encephalopathy, and coma prekoma hesitance accompanied hiperamoniyemiyeyu. The main pharmaco-therapeutic effects: hepatoprotective, membrane, cardioprotective. Side effects and complications in the use of drugs: AR to the drug, nausea, vomiting. Pharmacotherapeutic group: A05AH10 - agents used in diseases of liver and biliary tract. Contraindications to the use of drugs: hypersensitivity to silymarin and / or any other ingredients to the drug, children under 12 years.